Blog Posts (26)
September 21, 2016
by Kayhan Parsi, JD PhD
Protest singer Edwin Starr powerfully asked in the early 1970s: “War, what is it good for?” Apparently, it’s good enough to use in a variety of metaphorical turns of phrase.…
July 8, 2016
For my entire life, a half century and counting, healthcare spending in the U.S. has almost always risen faster than inflation. Sometimes it’s relatively slow, sometimes it’s relatively fast, but no matter the time, healthcare spending is climbing. Getting healthcare … Continue reading →
The post Three Things to Know about Future Healthcare Spending appeared first on PeterUbel.com.
May 25, 2016
by Craig Klugman, Ph.D.
I have a slide that I use when teaching my students about clinical ethics: “80% of ethics consults are about communication.” The only evidence base I have for this statement is a 2005 Norwegian study with a very small subject pool.…
May 25, 2016
There have been many wonderful new medications in the past decade or so, drugs that finally bring hope for many people with serious illnesses like rheumatoid arthritis, multiple sclerosis and even some advanced cancers. But these drugs often come at … Continue reading →
The post Specialty Drugs at Especially High Prices appeared first on PeterUbel.com.
March 18, 2016
Just three weeks earlier, she had noticed something strange about one of her breasts. An irregular shape. Her daughter brought her to the doctor, and soon the patient, I’ll call her Amanda, was diagnosed with breast cancer, stage “to be … Continue reading →
The post The Wrong Way To React When Terminally Ill Patients Cry appeared first on PeterUbel.com.
October 5, 2015
Here are some projections on what illnesses Medicare enrollees are experiencing now, and what they will be experiencing 20 years from now, courtesy of the Brookings Institute:
The post The Future of Disease – in One Picture appeared first on PeterUbel.com.
September 30, 2015
Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have … Continue reading →
The post Cancer Drugs Aren’t As Cost-Effective As They Used To Be appeared first on PeterUbel.com.
August 14, 2015
There has been lots written lately about the soaring cost of cancer care. You’re spending a lot on cancer recently in part because of many wonderful new treatments that come with a substantial price tag. But there has been less … Continue reading →
The post Which Cancers Do We Spend Most of Our Money On? appeared first on PeterUbel.com.
May 12, 2015
If you were a cancer center trying to get patients to come to receive care at your facility, what message would you send them? In other words, what would you as a cancer center director think people would value in … Continue reading →
The post What Do Cancer Centers Think Patients Are Looking For? appeared first on PeterUbel.com.
April 9, 2015
In the United States, the FDA tried to mandate that cigarette companies put nasty images of the harms of smoking onto cigarette packages, images that would take up at least half of the carton. It looks like that effort has … Continue reading →
The post Incentive to Stop Smoking? appeared first on PeterUbel.com.
View More Blog Entries
January 29, 2014 3:25 pm
Antioxidants do not protect against cancer in healthy people and may increase it or promote it in those who already do.
May 29, 2013 12:06 pm
A pioneering programme to test cancer patients for nearly 100 risk genes is to start in London and could represent the future of treatment in the NHS.
May 2, 2013 4:13 pm
Scientists have discovered that the most dangerous cancer of the uterine lining closely resembles the worst ovarian and breast cancers.
March 28, 2013 4:49 pm
More than 80 genetic ‘spelling mistakes’ that can increase the risk of breast, prostate and ovarian cancer have been found in a large, international research study within the framework of the EU Network COGS.
February 27, 2013 5:38 pm
The rate of advanced breast cancer for U.S. women 25 to 39 years old nearly doubled from 1976 to 2009, a difference too great to be a matter of chance, a study finds.
January 9, 2013 2:38 pm
A day after an exhaustive national report on cancer found the United States is making only slow progress against the disease, one of the country’s most iconic – and iconoclastic – scientists weighed in on “the war against cancer.” And he does not like what he sees.
September 20, 2012 8:42 pm
When Kirk Davis of Mount Holly, N.C., describes his wife’s cancer and subsequent treatment, he never says it was “her” diagnosis or chemo. He says “we were diagnosed with breast cancer” on June 2, 2008. The diagnosis, which was followed by medical bills and both having to take pay cuts, led to the Davis’ struggle to save their home from a scheduled foreclosure in December. Cindi Davis, 50, had to resign from her job as a school teacher to go on long-term disability. She said she has stage four cancer, now that it has spread to her lymph nodes, lungs and liver.
July 23, 2012 12:16 pm
The actions described by two prominent bioethicists as “astonishing,” and a “major penalty” for the school threaten both the doctors’ professional careers and the university’s reputation and federal-funding status. “This is really distressing” said Patricia Backlar, an Oregon bioethicist who served on President Bill Clinton’s national bioethics advisory commission. “UC Davis is a very respectable school, but even the best places have trouble,” Backlar said. “These men have put that school in jeopardy.”
July 11, 2012 6:53 pm
It was supposed to be a life-changing organ transplant. But the pancreas given to patient Rashia Wimley at the University of Chicago Medical Center in the summer of 2008 was cancerous, a lawsuit filed Monday alleges. Now Wimley, 39, says she’s been diagnosed with cancer as a result. Her lawsuit alleges the doctor who performed the transplant, the University of Chicago and the Gift of Hope Organ and Tissue Donor Network all acted carelessly and negligently by giving her the diseased organ.
July 10, 2012 12:30 pm
Ethicists ask whether those with money and connections should have options far out of reach for most patients before such treatments become a normal part of medicine. And will people of more limited means be tempted to bankrupt their families in pursuit of a cure at the far edges?
View More News Items